Cite

HARVARD Citation

    Borghetti, A. et al. (2019). SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV. Journal of antimicrobial chemotherapy. pp. 1035-1043. [Online]. 
  
Back to record